3.6. Safety
Changes in blood pressure, complete body composition, blood cell content, lipid parameters, renal function, and liver function were assessed. The change in Ht (%) was significantly lower in the YM group than in the placebo group (No side effects or severe or moderate AEs were observed during the intervention. Seventeen mild AEs were recorded during the study period. In the YM group, eleven AEs were recorded, including elevated ALT (